Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03141801 · ClinicalTrials.gov registry record · NA

Blood Flow Restriction to Improve Muscle Strength After ACL Injury

A NA study of Anterior Cruciate Ligament Injury, sponsored by University of Michigan.

Completed
Registry status
NA
Development phase
48
Enrollment target
1
Study location

NCT03141801: Completed NA study of Anterior Cruciate Ligament Injury, sponsored by University of Michigan.

NCT03141801 is a NA study of Anterior Cruciate Ligament Injury that has completed, run by University of Michigan. The registered enrollment target is 48 participants, below the 228-participant average among 8 other Anterior Cruciate Ligament Injury trials with a reported enrollment target (79% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03141801, a NA study of Anterior Cruciate Ligament Injury, has completed, sponsored by University of Michigan.

COMPLETED
Registry status
NA
Development phase
48 participants
Enrollment target
1
Study location

Study Summary

Quadriceps muscle weakness is a common consequence following anterior cruciate ligament (ACL) injury and reconstruction. Maximizing quadriceps strength following ACL injury is significant as diminished quadriceps strength has been linked to the osteoarthritis that affects over 50% of surgically reconstructed limbs. Given that knee joint health following ACL injury is predicated on restoring quadriceps strength, identifying treatment approaches capable of improving strength is paramount. Blood flow restriction training (BFRT) is a method where oxygen to the muscle is intentionally reduced during exercise/rehabilitation and may lead to more timely and substantial strength gains. In the proposed project, we will examine the efficacy of BFRT in patients who have undergone ACL reconstruction and suffer from substantial quadriceps weakness.

Primary Outcome

concentric isokinetic muscle strength at 60 degrees per second

Interventions

  • DEVICE DELFI PTS Personalized Tourniquet System for Blood Flow Restriction Training
  • OTHER Eccentric Exercise with BLAST Leg Press System
  • OTHER Concentric Exercise with BLAST Leg Press System

Study Locations (1)

Michigan

  • University of Michigan - Ann Arbor

Trial Details

FieldValue
Enrollment Target 48 participants
Start Date 2016-08-25
Est. Completion 2018-11-21
Phase NA
University of Michigan

1,327 total trials

What the finished NCT03141801 record still lists

NCT03141801 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 48 participants, a relatively small participant target, below the 228-participant average among 8 other Anterior Cruciate Ligament Injury trials with a reported enrollment target (79% lower).

The record links to 1 condition, with Anterior Cruciate Ligament Injury appearing as the primary indexed condition, and to 3 interventions - of which DELFI PTS Personalized Tourniquet System for Blood Flow Restriction Training is the first listed.

NCT03141801 reports a single indexed study location in Michigan.

Frequently Asked Questions

What is clinical trial NCT03141801 about?

NCT03141801 is a clinical study titled "Blood Flow Restriction to Improve Muscle Strength After ACL Injury". Quadriceps muscle weakness is a common consequence following anterior cruciate ligament (ACL) injury and reconstruction. Maximizing quadriceps strength following ACL injury is significant as diminished quadriceps strength has been linked to the osteoarthritis that affects over 50% of surgically reco...

What is the current status of trial NCT03141801?

This trial is currently completed. It is a NA study. The enrollment target is 48 participants. The study started on 2016-08-25. Estimated completion is 2018-11-21.

What conditions does trial NCT03141801 study?

This clinical trial studies the following conditions: Anterior Cruciate Ligament Injury.

What interventions are being tested in trial NCT03141801?

The interventions under investigation include: DELFI PTS Personalized Tourniquet System for Blood Flow Restriction Training (DEVICE), Eccentric Exercise with BLAST Leg Press System (OTHER), Concentric Exercise with BLAST Leg Press System (OTHER).

Who is sponsoring clinical trial NCT03141801?

This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03141801 being conducted?

This trial has 1 study location across Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Anterior Cruciate Ligament Injury

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT03141801's enrollment target sits among peer trials

48 5th of 8 higher than 3 of 8 other Anterior Cruciate Ligament Injury trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Anterior Cruciate Ligament Injury trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01765777 · 48 participants · NA

    Efficacy of Osteopathic Manipulative Medicine (OMM) and Phototherapy for Patients With Chronic Lower Back Pain

  • NCT03073343 · 48 participants · NA

    A Prospective, Randomized, Open Label Trial of Two Doses of Oral Betaine

  • NCT03431064 · 48 participants

    Lung Recruitment Maneuver as a Potential Predictor of Fluid Responsiveness in Mechanically Ventilated Pediatric Patients

  • NCT03514602 · 48 participants · NA

    Maternal Smoking Cessation and Pediatric Obesity Prevention

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03141801, the US trial registry maintained by the National Library of Medicine. NCT03141801 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.